Department of Public Health, Norwegian University of Science and Technology, Postboks 8905, N-7491 Trondheim, Norway.
Hum Reprod. 2014 Jun;29(6):1153-60. doi: 10.1093/humrep/deu068. Epub 2014 Apr 9.
Are low serum concentrations of human chorionic gonadotrophin (hCG) in very early pregnancy associated with pre-eclampsia risk?
Low hCG concentrations in very early pregnancy are associated with increased risk of severe pre-eclampsia.
Low maternal serum concentrations of hCG early in pregnancy may indicate impaired proliferation or invasion of trophoblast cells, and thus low hCG concentrations may serve as a marker for impaired placental development. Impaired placental development is assumed to be a cause of pre-eclampsia, but there is little prospective evidence to support this hypothesis.
STUDY DESIGN, SIZE, DURATION: We performed a prospective cohort study of pregnancies after IVF at Oslo University Hospital 1996-2010 with linkage to the Medical Birth Registry of Norway to obtain information on pre-eclampsia development.
PARTICIPANTS/MATERIALS, SETTING, METHODS: We included 2405 consecutive singleton pregnancies and examined the association of maternal serum hCG concentrations (measured using Elecsys, Roche) on Day 12 after embryo transfer with the risk of any pre-eclampsia and of mild and severe pre-eclampsia.
HCG concentrations were inversely associated with pre-eclampsia risk in a dose-dependent manner (Ptrend 0.02). Compared with women with hCG ≥150 IU/l, women with hCG <50 IU/l were at 2-fold higher overall risk of pre-eclampsia [absolute risk 6.4 versus 2.8%; odds ratio (OR) 2.3, 95% confidence interval (CI) 1.2-4.7]. The inverse association was restricted to severe pre-eclampsia (Ptrend 0.01), thus, women with hCG <50 IU/l were at 4-fold higher risk of severe pre-eclampsia than women with hCG ≥150 IU/l (absolute risk 3.6 versus 0.9%; OR 4.2, 95% CI 1.4-12.2). For mild pre-eclampsia, there was no corresponding association (Ptrend 0.36).
LIMITATIONS, REASONS FOR CAUTION: Results for IVF pregnancies may not be generalizable to spontaneously conceived pregnancies.
Plausible causes of low maternal hCG concentrations very early in pregnancy include impaired placental development and delayed implantation. Thus, these results provide prospective evidence to support the hypothesis that impaired placental development may be associated with subsequent development of severe pre-eclampsia.
STUDY FUNDING/COMPETING INTEREST: The study was financially supported by the Research Council of Norway. None of the authors has any conflict of interest to declare.
妊娠早期母体血清人绒毛膜促性腺激素(hCG)浓度低是否与子痫前期风险相关?
妊娠早期 hCG 浓度低与重度子痫前期风险增加相关。
妊娠早期母体血清 hCG 浓度低可能提示滋养细胞增殖或侵袭能力受损,因此 hCG 浓度低可能作为胎盘发育不良的标志物。胎盘发育不良被认为是子痫前期的一个原因,但很少有前瞻性证据支持这一假说。
研究设计、规模、持续时间:我们对 1996 年至 2010 年在奥斯陆大学医院进行的 IVF 后妊娠进行了前瞻性队列研究,并与挪威医学出生登记处进行了链接,以获取子痫前期发展的信息。
参与者/材料、设置、方法:我们纳入了 2405 例连续单胎妊娠,并检测了胚胎移植后第 12 天母体血清 hCG 浓度(使用 Elecsys,罗氏)与任何子痫前期、轻度子痫前期和重度子痫前期风险的相关性。
hCG 浓度与子痫前期风险呈剂量依赖性负相关(Ptrend 0.02)。与 hCG≥150IU/l 的妇女相比,hCG<50IU/l 的妇女子痫前期的总体风险高 2 倍[绝对风险 6.4%比 2.8%;比值比(OR)2.3,95%置信区间(CI)1.2-4.7]。这种负相关仅限于重度子痫前期(Ptrend 0.01),因此,hCG<50IU/l 的妇女发生重度子痫前期的风险是 hCG≥150IU/l 的妇女的 4 倍(绝对风险 3.6%比 0.9%;OR 4.2,95%CI 1.4-12.2)。对于轻度子痫前期,没有相应的相关性(Ptrend 0.36)。
局限性、谨慎的原因:体外受精妊娠的结果可能不适用于自然受孕妊娠。
妊娠早期母体 hCG 浓度低的合理原因包括胎盘发育不良和着床延迟。因此,这些结果提供了前瞻性证据,支持胎盘发育不良可能与随后发生重度子痫前期相关的假说。
研究资助/利益冲突:该研究得到挪威研究理事会的财政支持。作者均无任何利益冲突声明。